The new virus before the corona ends… Flash Langya explanation from Zhu Feng

Creation Date: August 16, 2022 11:21

The world, which has been fighting the coronavirus for more than 2 years, has been in a Langya panic in recent days. While the news from China caused the fear of a ‘new epidemic’, the hopeful news finally came.

class=”medianet-inline-adv”>

Coming into our lives in the last months of 2019 coronavirus (Covid-19) world It has cost millions of lives across the country.

The virus, which causes us to leave many of our habits behind, continues to change its shell, so to speak.

While many countries decide to relax after the more contagious but less lethal variant of Omicron ChineseThe news of the new virus from Turkey once again brought the epidemic to the agenda.

Langya Henipavirus, known as ‘Langya’, has been seen in dozens of people in the eastern provinces of China.

It is focused on the possibility that the virus, which was detected in people with a history of contact with animals, was transmitted to humans through creatures such as mice.

In this research, Dr. Zhu Feng made special statements to the British newspaper Mirror.

SYMPTOMS EXPLAINED ONE BY ONE

Stating that some patients with this virus develop severe symptoms such as pneumonia, Feng used the following statements;

class=”medianet-inline-adv”>

‘They all had a fever so they went to the hospital. Most had coughs or fatigue, but only a few showed serious symptoms such as pneumonia and low platelet counts.’

HOPELY EXPECTED EXPLANATION HAS COME: ALL GOOD

Dr Feng said Langya was not as deadly as Hendranipavirus or Nipah because none of those infected died or needed intensive care.

The researcher also underlined the information that everyone who caught the virus recovered.

Researchers found the virus in 71 of the 262 shrews tested after initial reports of infection.

The virus has been found in shrews as well as dogs and goats.

Stating that the virus in question should not cause panic, Dr. Feng said, “There is no need to panic because it is not a serious ongoing epidemic, but we still need continuous and active genomic and serological surveillance, based on transparent and international cooperation, as the number of cases is limited.” .

.